Skip to main content

Currently Skimming:

Appendix A: Workshop Agenda
Pages 187-191

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 187...
... This session will examine definitive and emerging associations between infectious agents and chronic diseases with a range of pathogenic mechanisms and diversity in etiologic microbes. The review will explore advances in research, detection, and 187
From page 188...
... 10:15 Infectious agents and demyelinating diseases Richard Johnson, Johns Hopkins University School of Medicine 10:45 The role of infectious agents in schizophrenia, bipolar disorder, and other serious neuropsychiatric diseases Robert Yolken and E Fuller Torrey, Johns Hopkins University School of Medicine and Stanley Foundation 11:15 BREAK 11:30 Common infections and uncommon disease: Elusive associations of enteroviruses and type I diabetes mellitus Mark Pallansch, Centers for Disease Control and Prevention 12:00 p.m.
From page 189...
... Continental Breakfast 9:00 Opening Remarks
From page 190...
... 9:15 Interaction of multiple infectious agents in endemic areas Altaf Lal, Centers for Disease Control and Prevention 9:45 Progression of hepatitis C virus infection with and without schistosomiasis Sanaa Kamal, Ain Shams University, Cairo, Egypt 10:15 Infectious agents and epilepsy J.W.A.S. Sander, Institute of Neurology, University College, London 10:45 Potential long-term consequences of early childhood enteric and parasitic infections Richard Guerrant, University of Virginia School of Medicine 11:15 HTLV-1: Clinical impact of chronic infection Eduardo Gotuzzo, University of Peru, Lima, Peru 12:00 p.m.
From page 191...
... Helena Mäkelä, National Public Health Institute, Helsinki, Finland 2:30 Integrating epidemiology, laboratory research, and surveillance Siobhán O'Connor, Centers for Disease Control and Prevention 3:00 BREAK Session VI Discussion Panel: The Next Steps for the Healthcare Community Panel members, Forum members, and the audience will comment on and respond to considerations such as the role of industry and academic research in developing treatments; the implications for the health care and prevention community in detecting and treating these diseases; and the benefits of managing acute infections vs. chronic diseases -- the argument for vaccines and antimicrobials.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.